13F-HR filed by INVESTOR AB
INVESTOR AB filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-14, with 7 holding rows worth $14,403,406,346.
- Accession
- 0001493152-26-038312
- Filer
- CIK 889232
- Filed
- 2026-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2026
A holdings report, 7 entries on the cover page, a total value of $14,403,406,346 stated on the cover page (in dollars after the unit check, H1), rows summing to $14,403,406,346 with VALUE read as dollars as filed, 13F file number 028-03431. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 51,587,810 | $9,782,080,532 | dollars as filed | |
| NASDAQ INC COM | 631103108 | Stock | 58,439,208 | $4,606,178,375 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 872,093 | $12,819,767 | dollars as filed | |
| CELLEBRITE DI LTD ORDINARY SHARES | M2197Q107 | Stock | 75,000 | $1,095,000 | dollars as filed | |
| Micron Technology,Inc. | 595112103 | COM | 470 | $542,516 | dollars as filed | |
| Verizon Communications Inc | 92343V104 | COM | 11,300 | $478,442 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 3,700 | $211,714 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-26-038312 | this filing | 2026-08-14 | acceptance time not in the bulk data set |